Malignancy
Live Stream
Sean Langenfeld, MD
Omaha
CME Credit: 0.75
Contact Hours: 0.75
Click Here to Access the Polling Questions.
The outcomes of rectal cancer treatment remain highly variable. Tremendous differences have been reported relative to sphincter-sparing versus permanent stoma operations, surgical morbidity, postoperative mortality, local tumor recurrence, use of non-operative, and survival. Further, variations also occur in the utilization of a multidisciplinary evaluation to include tumor board discussion, radiological staging, and pathological evaluation, as well as adjuvant/neoadjuvant chemoradiation therapy. More recently, there has been the involvement of the American College of Surgeons and the Commission on Cancer to educate and help implement a quality assurance program. Over the past few years, several novel approaches to treating both early-stage and locally advanced rectal cancer are challenging the traditional standard of care. While the novel treatment paradigms aim to tailor multidisciplinary management and offer options to patients based on their disease characteristics, it is critical for surgeons and physicians to understand: (1) the quality standards and benchmark outcomes associated with the standard of care: (2) the nature of novel treatment approaches as well as the extent and the strength of the evidence associated with them; (3) how to practically integrate above knowledge and apply them to make treatment recommendations and decisions in daily practice. This session will describe the key measures of high-quality rectal cancer care including surgical and multimodality therapies, summarize the benchmark outcomes that should be expected with the traditional standard of care, discuss novel treatment paradigms along with available evidence, and provide case examples illustrating the practical application of existing evidence.
Moderator: Sean Langenfeld, MD
Super Session Moderator: Sean Langenfeld, MD
Panelist: Steven Wexner, MD, PhD(Hon)
Panelist: Rodrigo Oliva Perez, MD, PhD
Panelist: Erin Kennedy, MD
Panelist: Amber Post, MD, PhD
Panelist: Matthew Mutch, MD